Compare iShares Core S&P 500 ETF (IVV) vs Revolution Medicines Inc. Common Stock (RVMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Core S&P 500 ETF vs Revolution Medicines Inc. Common Stock — how do they compare? iShares Core S&P 500 ETF trades at $781.71 (market cap $897.20B), while Revolution Medicines Inc. Common Stock trades at $191.06 (market cap $40.32B). The key difference: iShares Core S&P 500 ETF is far larger — about 22.3× Revolution Medicines Inc. Common Stock's market cap, and iShares Core S&P 500 ETF is trading nearer its 52-week high, Revolution Medicines Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares Core S&P 500 ETF for 46 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| IVV | RVMD | |
|---|---|---|
Market Cap | $897.20B | $40.32B |
Volume | 4,580,672 | 4,855,734 |
Sector | Broad Market / Factor | Health |
52-Week High | $782.58 | $221.15 |
52-Week Low | $634.93 | $47.50 |
Typical Hold Time | 46 Days | 0 Days |
Enterprise Value | — | $37.02B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IVV, tracking the S&P 500, trades at $779.68, down 0.12% on the day, with a bullish technical signal from moving averages and neutral oscillators. Recent news highlights mixed S&P 500 valuation signals, with earnings growth expected to slow in 2027 but historical seasonal patterns suggesting potential upside. The ETF's fundamentals reflect the index's aggregate metrics, with no company-specific financials reported.
Outlook remains cautiously optimistic given the bullish technical bias and index-level support, though risks include concentration in top holdings and macroeconomic headwinds. Investors gain diversified exposure to large-cap U.S. equities, but should monitor earnings trends and interest rate sensitivity.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares Core S&P 500 ETF
IVV tracks the performance of the S&P 500 Index, offering low-cost exposure to 500 of the largest US companies. It is a cornerstone for long-term investors seeking broad growth in the US stock market.
Read more on IVV →About Revolution Medicines Inc. Common Stock
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →
